Organ Preservation Market Overview
The Organ Preservation Market Size was valued at USD 0.3 billion in 2022 and is projected to grow from USD 0.31 Billion in 2023 to USD 0.55 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.8% during the forecast period (2023 - 2032). The demand is increasing due to rising organ failure rates worldwide, campaigns to promote organ donation, an aging population, and the presence of important actors in both developing and wealthy nations, thus driving the market growth of the Organ Preservation. These are just a few of the market drivers that are driving the market.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Organ Preservation Market Trends
Rising number of organ transplantation procedures worldwide driving the market growth
The primary drivers of the market expansion are the rising incidence of multiple organ failure and the rising number of organ transplantation procedures worldwide. A 2019 Health Resources & Services Administration report estimates that 36,528 organ transplants took place in the United States in 2018 and that 95.00% of adults there support organ donation. Additionally, it stated that 6,831 living donors and 10,722 deceased donors out of a total of 17,553 donors documented in 2018 were reported.
Moreover, several awareness efforts are projected to affect the industry favorably. The 12th of October, for instance, is recognized as European Day for Organ Donation and Transplantation. In addition, 41,000 patients received organ transplants in Europe in 2018, according to a report released by the Council of Europe in 2019. Hence, it is projected that these occurrences will encourage the expansion of the organ preservation industry during the coming years. Thus, this factor is driving the market CAGR.
The rate of kidney transplants is anticipated to increase due to the rising number of renal failure cases and chronic kidney illnesses. The Centers for Disease Control & Prevention (CDC) reported in 2019 that approximately 15.00% of adults in the United States had chronic kidney disease yearly. Similarly, the National Institute of Diabetes and Digestive and Kidney Diseases reported in 2019 that over 661,000 Americans have kidney failure, of which 468,000 people are on dialysis, and about 193,000 have undergone kidney transplantation. Consequently, it is projected that these factors will fuel the expansion of the organ transplantation market throughout the next years. Thus, it is anticipated that this aspect will accelerate Organ Preservation market revenue globally.
Organ Preservation Market Segment Insights
Organ Preservation Solution Insights
The market segments of Organ Preservation, based on solution includes University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution. The University of Wisconsin Solution segment held the majority share in 2022 in the Organ Preservation market data. Due to the solution's rising utilization and several benefits, the University of Wisconsin (UW) owned the greatest stake in 2022. Compared to previous treatments, the solution enables the preservation of human liver grafts for a period greater than 15 hours. Also, it makes it simple to transfer organs safely over long distances. It primarily aids in liver preservation and raises the success percentage of liver transplantation. It is projected that rising liver transplantation rates will fuel market expansion.
Organ Preservation, Preservation Techniques Insights
The Organ Preservation market segmentation, based on preservation techniques, includes static cold storage, and dynamic cold storage. The static cold storage segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Due to its broad applicability and rising use, the static cold storage category had the greatest share in 2019. The main purpose of static cold storage is kidney preservation. Yet it is also employed in the preservation of other organs. Also, the existence of numerous market participants who provide static cold storage would foster the segment's expansion, hence contributing in the market growth of the Organ Preservation.
Figure 2 Organ Preservation Market, by Preservation Techniques, 2022 & 2030 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Organ Preservation Organ Type Insights
The market segmentation of Organ Preservation, based on organ type includes kidney, liver, heart, and lungs. The kidney segment held the majority share in 2022 in the Organ Preservation market data. The main factors impacting the market growth are the rising number of renal failure sufferers and kidney transplant surgeries worldwide. In the United States, around 37.00 million people have chronic kidney disease, and nearly 726,000 people each year have end-stage renal disease, according to a report released by the NHS in 2019. It is also projected that various kidney transplant awareness campaigns will aid in segment expansion.
Organ Preservation End-User Insights
The Organ Preservation market segmentation, based on end-user, includes hospitals & clinics, and organ banks. The organ banks segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The primary reason fueling the acceptance of this end-user category and accelerating market expansion is the rise of transplant facilities worldwide, hence contributing in the market growth of the Organ Preservation.
Organ Preservation Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Organ Preservation market accounted for USD 0.137 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The main drivers of growth are the increasing acceptance of cutting-edge healthcare technologies, the high prevalence of chronic renal disease and heart failure, better reimbursement rules, and rising investments in expanding healthcare infrastructure. The regional market is also anticipated to rise due to the aging population and an increase in organ transplant surgeries. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.
Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3 ORGAN PRESERVATION MARKET SHARE BY REGION 2022 (%)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Organ Preservation market accounts for the second-largest market share. The demand for facilities for lever preservation for transplants has been further stimulated by the costs associated with healthcare in European nations. The demand for organ transplant surgeries in this area would be further augmented by the incidence of additional severe disorders linked to the cardiovascular and renal systems. Moreover, UK market of Organ Preservation held the largest market share, and the Germany market of Organ Preservation was the fastest growing market in the region.
Asia Pacific Organ Preservation Market is expected to grow at the fastest CAGR from 2022 to 2030. This can be attributed to expanding patient awareness, rising healthcare costs, and growing demand for organ transplant treatments. In the years to come, it is also projected that the aging population, increased kidney and heart failure rates, and rising healthcare costs will contribute to the market's expansion. Further, the China market of Organ Preservation held the largest market share, and the India market of Organ Preservation was the fastest-growing market in the region.
Organ Preservation Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the Organ Preservation market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Organ Preservation industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the Organ Preservation industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Organ Preservation industry has provided medicine with some of the most significant benefits. The Organ Preservation market major player such Bristol Myers Squibb, Artivion Inc, Xvivo Perfusion AB, Accord Healthcare Limited, BioLife Solutions Inc, Shanghai Genext Medical Technology Co.Ltd.
Mimetas is a privately held biotechnology firm that creates goods and tissue models of human organs on a chip for drug development. The organization also does chemical testing with food and tailored medical applications. OrganoPlate Caco-2, a product line for organs on a chip, was introduced by MIMETAS in March 2020. Thirty-eight intestinal tubules formed in this product while flowing against an extracellular matrix. This product's development aimed to make Organ-on-a-Chip technology accessible to everyone. As a result, it is projected that this campaign will improve the company's market share.
Organ transport and preservation devices are made, sold, and designed by Paragonix Technologies to protect organs while they are being transported from donors to recipients. Our distinguished products reduce risk in a setting with high stakes. The Paragonix SherpaPak systems combine clinically tested and medically regarded cold preservation procedures in a revolutionary suspension system to offer unrivaled thermal and physical protection. The LIVERguard Donor Liver Preservation System was launched in both the US and Europe in November 2021 by Paragonix Technologies, a producer of donor organ preservation and transit systems.
Key Companies in the Organ Preservation Market Includes
Organ Preservation Industry Developments
January 2022 A university branch of Premarket clearance (PMA) for their metra system has been granted by the Food and Drug Administration, according to Organix, a leader in normothermic machine perfusion (NMP). Researchers in biomedical engineering and surgery have developed the ground-breaking organ preservation tool known as the OrganOx metra.
August 2022 Almost 2,000 donor organs have been preserved by Paragonix Technologies, Inc., which also offers transplant hospitals Advanced Organ Preservation (AOPT) technology and a statewide clinical support network.
Organ Preservation Market Segmentation
Organ Preservation Solution Outlook (USD Billion, 2018-2030)
- University of Wisconsin Solution
- Custodial HTK
- Collins Solution
- Celsior Solution
- Perfadex
- Citrate Solution
Organ Preservation Preservation Techniques Outlook (USD Billion, 2018-2030)
- Techniques Static Cold Storage
- Dynamic Cold Storage
Organ Preservation Organ Type Outlook (USD Billion, 2018-2030)
Organ Preservation End-User Outlook (USD Billion, 2018-2030)
- Hospitals & Clinics
- Organ Banks
Organ Preservation Regional Outlook (USD Billion, 2018-2030)
North America
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
Rest of the World
-
Middle East
-
Africa
-
Latin America
Organ Preservation Report Scope
Report Attribute/Metric |
Details |
Market Size 2022 |
USD 0.3 billion |
Market Size 2023 |
USD 0.319 billion |
Market Size 2032 |
USD 0.55 billion |
Compound Annual Growth Rate (CAGR) |
 5.8% (2023-2032) |
Base Year |
2022 |
Market Forecast Period |
2023-2032 |
Historical Data |
2018 - 2021 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Solution, Perseveration Techniques, Organ Type, End-User and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and Rest of the World |
Countries Covered |
The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled |
Bristol Myers Squibb, Artivion Inc, Xvivo Perfusion AB, Accord Healthcare Limited, BioLife Solutions Inc, Shanghai Genext Medical Technology Co.Ltd. |
Key Market Opportunities |
Increasing government initiatives related to organ transplantation |
Key Market Dynamics |
Rising number of organ transplantation procedures worldwide |
Frequently Asked Questions (FAQ) :
The Organ Preservation market size was valued at USD 1.6 Billion in 2022.
The market is projected to grow at a CAGR of 5.8% during the forecast period, 2023-2032.
North America had the largest share in the market
The key players in Organ Preservation market are Bristol Myers Squibb, Artivion Inc, Xvivo Perfusion AB, Accord Healthcare Limited, BioLife Solutions Inc, Shanghai Genext Medical Technology Co.Ltd.
The University of Wisconsin Solution category dominated the market in 2022.
The Organ Banks had the largest share in the market.